Literature DB >> 10561590

Identification of a CK2 phosphorylation site in mdm2.

C Götz1, S Kartarius, P Scholtes, W Nastainczyk, M Montenarh.   

Abstract

Mdm2 is a cellular oncoprotein the most obvious function of which is the down-regulation of the growth suppressor protein p53. It represents a highly phosphorylated protein but only little is yet known about the sites phosphorylated in vivo, the kinases that are responsible for the phosphorylation or the functional relevance of the phosphorylation status. Recently, we have shown that mdm2 is a good substrate for protein kinase CK2 at least in vitro. Computer analysis of the primary amino acid sequence of mdm2 revealed 19 putative CK2 phosphorylation sites. By using deletion mutants of mdm2 and a peptide library we identified the serine residue at position 269 which lies within a canonical CK2 consensus sequence (EGQELSDEDDE) as the most important CK2 phosphorylation site. Moreover, by using the mdm2 S269A mutant for in vitro phosphorylation assays this site was shown to be phosphorylated by CK2. Binding studies revealed that phosphorylation of mdm2 at S269 does not have any influence on the binding of p53 to mdm2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10561590     DOI: 10.1046/j.1432-1327.1999.00882.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2.

Authors:  Nerea Allende-Vega; Lynsey McKenzie; David Meek
Journal:  Mol Cell Biochem       Date:  2008-06-12       Impact factor: 3.396

Review 2.  Induction and activation of the p53 pathway: a role for the protein kinase CK2?

Authors:  David W Meek; Miranda Cox
Journal:  Mol Cell Biochem       Date:  2011-07-19       Impact factor: 3.396

3.  Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2.

Authors:  Nerea Allende-Vega; Sylvia Dias; Diane Milne; David Meek
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

4.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

Authors:  R Maya; M Balass; S T Kim; D Shkedy; J F Leal; O Shifman; M Moas; T Buschmann; Z Ronai; Y Shiloh; M B Kastan; E Katzir; M Oren
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

5.  Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.

Authors:  M Hjerrild; D Milne; N Dumaz; T Hay; O G Issinger; D Meek
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

6.  Therapeutic considerations for Mdm2: not just a one trick pony.

Authors:  Jason A Lehman; Jacob A Eitel; Christopher N Batuello; Lindsey D Mayo
Journal:  Expert Opin Drug Discov       Date:  2008-11       Impact factor: 6.098

7.  Preimplantation embryo development in the mouse requires the latency of TRP53 expression, which is induced by a ligand-activated PI3 kinase/AKT/MDM2-mediated signaling pathway.

Authors:  X L Jin; V Chandrakanthan; H D Morgan; C O'Neill
Journal:  Biol Reprod       Date:  2008-10-15       Impact factor: 4.285

Review 8.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

Review 9.  Activation and activities of the p53 tumour suppressor protein.

Authors:  E Bálint E; K H Vousden
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

10.  Ablation of beta subunit of protein kinase CK2 in mouse oocytes causes follicle atresia and premature ovarian failure.

Authors:  Qiu-Xia Liang; Zhen-Bo Wang; Fei Lin; Chun-Hui Zhang; Hong-Mei Sun; Liang Zhou; Qian Zhou; Heide Schatten; Filhol-Cochet Odile; Boldyreff Brigitte; Qing-Yuan Sun; Wei-Ping Qian
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.